Data from seven centers on the actuarial survival of implantable cardiac rhythm management devices may suggest general patterns for target durations of adequate performance.
Answers are grounded in this paper and cite their sources.
May inform device longevity expectations clinically; hypothesis-generating for performance benchmarks, requiring prospective validation before practice change.
Our data represent use, follow-up, and management decisions from seven independently functioning centers and most importantly, actuarial survival of ICRMDs that have been implanted for sufficient time period to allow assessment of time versus failure. General patterns of possible target durations for adequate performance for present or future generations of similar clinical devices may be suggested by the data that we have presented. However, it would be inappropriate to conclude from these data that any presently implanted ICRMD would have a particular functional reliability. These data, furthermore, only summarized device hardware performance and cannot and must not be used to determine either short-term or long-term individual patient status, management, or outcome.
No takes yet. Share an insight, caveat, or question.
SUSAN L. SONG (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: